- · 《环境昆虫学报》栏目设[09/30]
- · 《环境昆虫学报》数据库[09/30]
- · 《环境昆虫学报》投稿方[09/30]
- · 《环境昆虫学报》征稿要[09/30]
- · 《环境昆虫学报》刊物宗[09/30]
溃疡性结肠炎患者及其配偶的肠道菌群构成与多(3)
作者:网站采编关键词:
摘要:综上所述,考拉杆菌属、奥尔森菌属及克雷伯菌属可作为UC肠道菌群失调预后及治疗的潜在生物学标志物。此外,人体肠道菌群结构与数量因生活环境的不
综上所述,考拉杆菌属、奥尔森菌属及克雷伯菌属可作为UC肠道菌群失调预后及治疗的潜在生物学标志物。此外,人体肠道菌群结构与数量因生活环境的不同会产生一定差异,但这种差异不一定会引起机体发病,多种因素共同作用导致UC易感人群的肠道微环境失衡是UC的重要发病机制。
[1]NG SC, SHI HY, HAMIDI N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies[J]. Lancet, 2018,390(): 2769-2778.
[2]SHARARA A I, AL AWADHI S, ALHARBI O, et , disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East[J]. Expert Review of Gastroenterol Hepatology, 2018, 12(9): 883-897.
[3]PETERSEN A M, SARTOR R B, WU G D. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches[J]. Gastroenterol, 2017,152(2): 327-339. e4.
[4]MIRSEPASI-LAURIDSEN H C, VALLANCE B A,KROGFELT K A, et al. Escherichia coli pathobionts associated with inflammatory bowel disease[J]. Clinical Microbiology Reviews, 2019, 32(2): e00060-e18.
[5]LóPEZ-SERRANO P, PéREZ-CALLE J L, PéREZFERNáNDEZ M T, et al. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis:A: Spanish case-control study[J]. Scandinavian Journal of Gastroenterology, 2010, 45(12): 1464-1471.
[6]中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见 (2018年, 北京)[J]. 中华消化杂志, 2018, 38:292-311.
[7]YANG DONG HONG, ZHANG YUAN YUAN, DU PENG CHENG, et al. Rapid identification of bacterial species associated with bronchiectasis via metagenomic approach[J]. Biomed Environ Sci, 2014, 27(11): 888-901.
[8]ZHANG M, SUN K, WU Y, et al. Interactions between intestinal microbiota and host immune response in inflammatory bowel disease[J]. Front Immunol, 2017, 8: 942.
[9]SCHOULTZ I, KEITA ?V. Cellular and molecular therapeutic targets in inflammatory bowel disease-focusing on intestinal barrier function[J]. Cells, 2019, 8(2): 193.
[10]LI H, FAN C, LU H, et al. Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions[J]. Acta Pharm Sin B, 2020, 10(3): 447-461.
[11]ABHIJIT MAJI, RICHA MISRA, DARSHAN B DHAKAN, et al. Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers[J]. Environ Microbiol, 2018, 20(1):402-419.
[12]DANIELA PARADA VENEGAS, MARJORIE K DE LA FUENTE, GLAUBEN LANDSKRON, et al. Short Chain Fatty Acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases[J]. Front Immunol, 2019, 10: 277.
[13]LUKAS BAJER, MILOSLAV KVERKA, MARTIN KOSTOVCIK, et al. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis[J].World J Gastroenterol, 2017, 23(25): 4548-4558.
[14]HONG SHEN, ZHONGYAN LU, ZHAN CHEN, et al. Rapid fermentable substance modulates interactions between ruminal commensals and toll-like receptors in promotion of immune tolerance of goat rumen[J]. Front Microbiol, 2016, 7: 1812.
[15]BRUCE A ROSA, TANIAWATI SUPALI, LINCOLN GANKPALA, et al. Differential human gut microbiome assemblages during soil-transmitted helminth infections in indonesia and liberia[J]. Microbiome, 2018, 6(1): 33.
[16]STEINAR TRAAE BJ?RKHAUG, H?VARD AANES,SUDAN PRASAD NEUPANE, et al. Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption[J]. Gut Microbes, 2019, 10(6): 663-675.
[17]NOBUHIRO NAKAMOTO, NOBUO SASAKI, RYO AOKI,et al. Gut pathobionts underlie intestinal barrier dysfunction and liver t helper 17 cell immune response in primary sclerosing cholangitis[J]. Nat Microbiol, 2019, 4(3): 492-503.
文章来源:《环境昆虫学报》 网址: http://www.hjkcxbzz.cn/qikandaodu/2021/0610/1509.html
上一篇:绿色环境暴露与青年人脑灰质体积及自发性脑活
下一篇:环境化学物与型糖尿病肾脏疾病